Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus

doi:10.4239/wjd.v15.i4.606

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2340)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

159

HTML

1632

Figures (1-2)

215

Sum=2006

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

147

Sum=204

Apr 15, 2024 (publication date) through Jan 3, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Apr 15, 2024; 15(4): 606-622
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.606

Full Size Figure Download Figure

Figure 1 Renin angiotensin aldosterone system: Its components and workflow. ACE: Angiotensin-converting enzyme; ACE2: Angiotensin-converting enzyme 2; ACEi: Angiotensin-converting enzyme inhibitor; Ang(1-7): Angiotensin 1-7; Ang(1-9): Angiotensin 1-9; Ang-I: Angiotensin I; Ang-II: Angiotensin II; ARBs: Angiotensin-II receptor blockers; AT1R: Angiotensin-II type 1 receptor; MasR: MasR receptor.

Citation: Shukla AK, Awasthi K, Usman K, Banerjee M. Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus. World J Diabetes 2024; 15(4): 606-622
URL: https://www.wjgnet.com/1948-9358/full/v15/i4/606.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i4.606